CRM Publications

Bird TG, Lu W-Y, Boulter L, Gordon-Keylock S, Ridgway RA, Williams MJ, Taube J, Thomas JA, Wojtacha D, Gambardella A et al..  2013.  Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling.Proc Natl Acad Sci U S A. 110(16):6542-7.

Corselli M, Crisan M, Murray IR, West CC, Scholes J, Codrea F, Khan N, Péault B.  2013.  Identification of perivascular mesenchymal stromal/stem cells by flow cytometry.Cytometry A. 83(8):714-20.

Borooah S, Phillips MJ, Bilican B, Wright AF, Wilmut I, Chandran S, Gamm D, Dhillon B.  2013.  Using human induced pluripotent stem cells to treat retinal disease.Prog Retin Eye Res. 37:163-81.

Crisan M, Corselli M, Chen WCW, Péault B.  2012.  Perivascular cells for regenerative medicine.J Cell Mol Med. 16(12):2851-60.

Ivanovs A, Rybtsov S, Welch L, Anderson RA, Turner ML, Medvinsky AL.  2011.  Highly potent human hematopoietic stem cells first emerge in the intraembryonic aorta-gonad-mesonephros region.J Exp Med. 208(12):2417-27.

Huang JK, Jarjour AA, ffrench-Constant C, Franklin RJM.  2011.  Retinoid X receptors as a potential avenue for regenerative medicine in multiple sclerosis.Expert Rev Neurother. 11(4):467-8.

Connick P, Patani R, Chandran S.  2011.  Stem cells as a resource for regenerative neurology.Pract Neurol. 11(1):29-36.

Hay DC, Ross JA, Gallagher R, Bagnaninchi PO.  2010.  The complexities of engineering human stem cell-derived therapeutics.J Biomed Biotechnol. 2010:654964.

Mountford JC, Olivier E, Jordanides NE, de Sousa P, Turner ML.  2010.  Red blood cells from pluripotent stem cells for use in transfusion.Regen Med. 5(3):411-23.

Dalgetty D, Medine C.N, Iredale JP, Hay DC.  2009.  Progress and future challenges in stem cell-derived liver technologies.Am J Physiol Gastrointest Liver Physiol. 297(2):G241-8.